Submitted by Anonymous (not verified) on 27 January 2026 - 10:30
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 18, Status: Authorised